Table of Contents
FDA TSE Advisory Committee Meeting October 25, 2001 Topic 2 Amino Acid Production and the Associated Theoretical Risk of BSE Transmission from their Use in the Production of Biologics, Drugs and Medical Devices
PPT Slide
Review of Tallow and Gelatin
Production of Amino Acids
Amino Acids in FDA-Regulated Drugs
Amino Acids in FDA-Regulated Drugs (cont)
Active Ingredients
Amino Acids in FDA-Regulated Drugs (cont)
Amino Acids in FDA-Regulated Drugs (cont)
Excipients and Reagents
Sponsors’ Responses to Request for Information
Suppliers’ Response to Request for Information
Amino Acid Manufacturers
Charge to the Committee
Charge to the Committee (cont)
Charge to the Committee (cont)
TSEAC 25 October, 2001 Topic 2: Safety of Amino Acids
TSEAC 25 October, 2001 Topic 2: Safety of Amino Acids
TSEAC 25 October, 2001 Topic 2: Safety of Amino Acids
TSEAC 25 October, 2001 Topic 2: Safety of Amino Acids
|